Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2024-11-20 5:21 pm Purchase | 13G | OPTINOSE INC OPTN | Stonepine Capital Management LLC | 8,174,631 5.400% | 8,174,631 (New Position) | View |
2024-11-14 4:54 pm Purchase | 13G | OPTINOSE INC OPTN | GREAT POINT PARTNERS LLC | 15,306,939 9.990% | 3,822,819 (+33.29%) | View |
2024-11-12 10:32 am Purchase | 13G | OPTINOSE INC OPTN | FMR LLC | 18,675,561 12.213% | 1,874,908 (+11.16%) | View |
2024-10-18 2:52 pm Purchase | 13G | OPTINOSE INC OPTN | Rosalind Advisors Inc. | 8,287,503 5.500% | 740,355 (+9.81%) | View |
2024-05-29 3:32 pm Purchase | 13G | OPTINOSE INC OPTN | Rosalind Advisors Inc. | 7,547,148 7.750% | 3,005,659 (+66.18%) | View |
2024-04-25 7:01 pm Sale | 13G | OPTINOSE INC OPTN | Rosalind Advisors Inc. | 4,541,489 5.140% | -344,091 (-7.04%) | View |
2024-02-22 4:28 pm Sale | 13G | OPTINOSE INC OPTN | Rosalind Advisors Inc. | 4,885,580 4.400% | -1,549,420 (-24.08%) | View |
2024-02-14 8:48 pm Unchanged | 13G | OPTINOSE INC OPTN | Rosalind Advisors Inc. | 479,990 5.200% | 0 (Unchanged) | View |
2024-02-14 4:38 pm Purchase | 13G | OPTINOSE INC OPTN | GREAT POINT PARTNERS LLC | 11,484,120 9.990% | 169,401 (+1.50%) | View |
2024-02-13 5:16 pm Purchase | 13G | OPTINOSE INC OPTN | ACORN BIOVENTURES L.P. | 12,042,008 9.900% | 673,050 (+5.92%) | View |
2024-02-09 09:28 am Purchase | 13G | OPTINOSE INC OPTN | FMR LLC | 16,800,653 14.680% | 2,139,543 (+14.59%) | View |
2024-02-07 4:15 pm Purchase | 13G | OPTINOSE INC OPTN | KRUTTSCHNITT THEODORE H III | 9,105,789 7.980% | 474,211 (+5.49%) | View |
2024-01-30 4:05 pm Sale | 13G | OPTINOSE INC OPTN | Avista Capital Partners II GP LLC | 0 0.000% | -14,273,017 (Position Closed) | View |
2023-07-27 6:09 pm Purchase | 13G | OPTINOSE INC OPTN | Rosalind Advisors Inc. | 6,435,000 5.800% | 6,435,000 (New Position) | View |
2023-02-14 5:00 pm Unchanged | 13G | OPTINOSE INC OPTN | GREAT POINT PARTNERS LLC | 11,314,719 9.990% | 0 (Unchanged) | View |
2023-02-14 4:05 pm Purchase | 13D | OPTINOSE INC OPTN | MVM Partners LLC | 16,710,526 14.900% | 4,210,526 (+33.68%) | View |
2023-02-09 12:01 pm Purchase | 13G | OPTINOSE INC OPTN | FMR LLC | 14,661,110 13.347% | 2,698,545 (+22.56%) | View |
2023-01-19 5:24 pm Purchase | 13G | OPTINOSE INC OPTN | KRUTTSCHNITT THEODORE H III | 8,631,578 7.470% | 4,465,402 (+107.18%) | View |
2022-12-05 4:30 pm Purchase | 13G | OPTINOSE INC OPTN | ACORN BIOVENTURES L.P. | 11,368,958 9.900% | 11,368,958 (New Position) | View |
2022-12-01 4:03 pm Purchase | 13G | OPTINOSE INC OPTN | GREAT POINT PARTNERS LLC | 11,314,719 9.990% | 11,314,719 (New Position) | View |